ArriVent BioPharma Inc

Research ArriVent BioPharma Inc (AVBP) on Bullrun: market cap USD 1.56B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerAVBP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.56B
• Financial periodFY2025
• Net income-USD 166.31M

Valuation Snapshot

latest market cap is USD 1.56B.

About ArriVent BioPharma Inc

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.

Frequently asked questions

What is ArriVent BioPharma Inc's market cap?

ArriVent BioPharma Inc's market capitalization is USD 1.56B.

What does ArriVent BioPharma Inc do?

ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.